SCHEMBL203115

SCHEMBL203115

C=C(C)C(=O)Nc1ccc(C(=O)c2ccccc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.69
L3MBTL1 Q9Y468 1/20 0.69
RAB9A P51151 4/20 0.61
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
NPC1 O15118 2/20 0.61
SMN1; SMN2 Q16637 3/20 0.58
HPGD P15428 2/20 0.58
TDP1 Q9NUW8 2/20 0.58
HTT P42858 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
FFAR1 O14842 1/20 0.56
RXFP1 Q9HBX9 1/20 0.56
CYP19A1 P11511 2/20 0.55
MAPK13 O15264 1/20 0.55
MAPK12 P53778 1/20 0.55
MAPK11 Q15759 1/20 0.55
MAPK14 Q16539 1/20 0.55
CACNA1B Q00975 1/20 0.53
APBA1 Q02410 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10050685 0.91 ALDH1A1 (0.58) ALDH1A1L3MBTL1RAB9AMEN1KMT2A
SCHEMBL23980745 0.89 ELANE (0.61) ALDH1A1L3MBTL1RAB9AMEN1KMT2A
SCHEMBL25928974 0.87 TDP1 (0.55) ALDH1A1L3MBTL1RAB9AMEN1KMT2A
SCHEMBL219147 0.85 KDM4E (0.66) ALDH1A1L3MBTL1RAB9AKMT2ANPC1
SCHEMBL345555 0.84 RXFP1 (0.61) ALDH1A1L3MBTL1RAB9AMEN1KMT2A
SCHEMBL439393 0.83 RXFP1 (0.74) ALDH1A1L3MBTL1RAB9AMEN1KMT2A
SCHEMBL166821 0.82 MAPT (0.67) ALDH1A1RAB9AMEN1KMT2ANPC1
SCHEMBL19501001 0.82 NPC1 (0.67) ALDH1A1RAB9AMEN1KMT2ANPC1
Dimethylamine SCHEMBL10625504 0.82 KDM4E (0.61) ALDH1A1L3MBTL1RAB9AKMT2ANPC1
SCHEMBL17299114 0.82 RXFP1 (0.62) ALDH1A1L3MBTL1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116815497-A Preparation method of high-antibacterial wear-resistant non-woven fabric 杨长根 2023-09-29 CN claimed
EP-4663688-A2 CROSSLINKERS Hemoteq AG (DE) 2025-12-17 EP disclosed
EP-4584243-B1 CROSSLINKERS HEMOTEQ AG (DE) 2025-11-05 EP disclosed
EP-4584243-A1 CROSSLINKERS Hemoteq AG (DE) 2025-07-16 EP disclosed
WO-2025056814-A1 CROSSLINKERS HEMOTEQ AG (DE) 2025-03-20 WO disclosed
EP-4524128-A1 BENZOPHENONE CROSSLINKERS Hemoteq AG (DE) 2025-03-19 EP disclosed
CN-111971621-B Colorant composition, photosensitive material, color filter and display device 株式会社LG化学 2024-05-07 CN disclosed
CN-112204465-B Photosensitive resin composition, photosensitive material, color filter and display device 株式会社LG化学 2024-04-02 CN disclosed
CN-116815497-A Preparation method of high-antibacterial wear-resistant non-woven fabric 杨长根 2023-09-29 CN disclosed
CN-116815497-A Preparation method of high-antibacterial wear-resistant non-woven fabric 杨长根 2023-09-29 CN disclosed
US-20090131365-A1 NOVEL HETEROCYCLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) ZHANG XUQING 2009-05-21 US disclosed
US-20090131365-A1 NOVEL HETEROCYCLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) ZHANG XUQING 2009-05-21 US disclosed
US-20090131365-A1 NOVEL HETEROCYCLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) ZHANG XUQING 2009-05-21 US disclosed
US-7465809-B2 Heterocycle derivatives useful as selective androgen receptor modulators (SARMs) JANSSEN PHARMACEUTICA N.V. (BG) 2008-12-16 US disclosed
US-7465809-B2 Heterocycle derivatives useful as selective androgen receptor modulators (SARMs) JANSSEN PHARMACEUTICA N.V. (BG) 2008-12-16 US disclosed
US-7465809-B2 Heterocycle derivatives useful as selective androgen receptor modulators (SARMs) JANSSEN PHARMACEUTICA N.V. (BG) 2008-12-16 US disclosed
CN-101103003-A Novel heterocyclic derivatives as Selective Androgen Receptor Modulators (SARMS) JANSSEN PHARMACEUTICA NV (BE) 2008-01-09 CN disclosed
EP-1817292-A2 NOVEL HETEROCYCLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) JANSSEN PHARMACEUTICA N.V. (BE) 2007-08-15 EP disclosed
US-20060211756-A1 Novel heterocycle derivatives useful as selective androgen receptor modulators (SARMs) JANSSEN PHARMACEUTICA N.V. (BE) 2006-09-21 US disclosed
WO-2006055184-A2 NOVEL HETEROCYCLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211756-A1 Novel heterocycle derivatives useful as selective androgen receptor modulators (SARMs) AR, NR5A1, NR5A2 ALDH1A1 1240/4885L3MBTL1 4796/4885RAB9A 3036/4885
US-20090131365-A1 NOVEL HETEROCYCLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AR, NR5A1, NR5A2 ALDH1A1 1240/4885L3MBTL1 4796/4885RAB9A 3036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.